Agilon Health, Inc. (NYSE:AGL – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $119.25 and last traded at $117.7050, with a volume of 554 shares traded. The stock had previously closed at $119.25.
Wall Street Analyst Weigh In
Several brokerages have commented on AGL. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and increased their price target for the company from $33.00 to $49.00 in a report on Thursday, May 7th. Citigroup reaffirmed a “neutral” rating and set a $80.00 price objective (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and raised their target price for the company from $27.50 to $48.00 in a research note on Thursday, May 7th. Weiss Ratings downgraded shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Finally, Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Agilon Health presently has an average rating of “Hold” and an average target price of $58.73.
View Our Latest Stock Report on Agilon Health
Agilon Health Trading Down 5.9%
Agilon Health (NYSE:AGL – Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Research analysts predict that Agilon Health, Inc. will post -3.5 EPS for the current fiscal year.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the company. Alpine Global Management LLC acquired a new position in shares of Agilon Health in the 4th quarter worth approximately $84,000. Simplify Asset Management Inc. boosted its stake in Agilon Health by 92.0% in the 4th quarter. Simplify Asset Management Inc. now owns 218,810 shares of the company’s stock valued at $151,000 after buying an additional 104,834 shares in the last quarter. GSA Capital Partners LLP acquired a new stake in Agilon Health in the 4th quarter valued at $1,408,000. UBS Group AG grew its position in Agilon Health by 250.7% in the fourth quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock valued at $2,339,000 after acquiring an additional 2,427,136 shares during the period. Finally, Krilogy Financial LLC acquired a new position in Agilon Health during the fourth quarter worth $34,000.
About Agilon Health
Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.
Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.
Read More
- Five stocks we like better than Agilon Health
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
